Vimarsana
Biggest News Aggregation in the World

Page 13 - Mark Crossley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Crossley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Crossley Today - Breaking & Trending Today

Pandemic-delayed retirements hitting FDA - Vimarsana News

Pandemic-delayed retirements hitting FDA

Many FDA employees who felt they could not leave federal service during the Covid-19 pandemic are starting to think about retirement and other plans.

Indivior Reaches Agreement with States' Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims - Vimarsana News

Indivior Reaches Agreement with States' Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims

* Indivior Reaches Agreement with States' Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims Richmond, VA --- Indivior PLC , a leading addiction... | June 5, 2023

Indivior reaches settlement in litigation with US states - Vimarsana News

Indivior reaches settlement in litigation with US states

Addiction treatment-focussed pharmaceuticals company Indivior announced on Monday that its subsidiary Indivior Inc has successfully reached an agreement to resolve the claims brought against it by the attorneys general of 41 US states and the District of Columbia.

Ohio gets cut of $102 million antitrust settlement with drug company treating opioid addiction - Vimarsana News

Ohio gets cut of $102 million antitrust settlement with drug company treating opioid addiction

The federal lawsuit claimed Indivior Inc. made changes to its product to extend the patent, preventing other companies from making cheaper alternatives.

Source: wosu.org
Addiction drug maker will pay more than $102 million fine for stifling competition - Vimarsana News

Addiction drug maker will pay more than $102 million fine for stifling competition

Indivior was accused of using illegal strategies to keep generic versions of the opioid-treatment medication Suboxone off the market. The company denies wrongdoing.

Source: wpsu.org